US Biotech Market Analysis

Published by: RNCOS

Published: Mar. 1, 2007 - 65 Pages

Table of Contents

1. Analyst View

2. Research Overview

3. Industry Overview

3.1 Biotechnology Industry Worldwide

3.2 US Biotech Industry

4. Industry Performance

4.1 Bio Medical

4.1.1 Current Biomedical Business Models

4.1.1.1 Fully Integrated Companies (FICOs: FIPCOs, FIBCOs, FICOPs)

4.1.1.2 Non Research Development Only (NRDOs)

4.1.1.3 Platform Model

4.1.1.4 Mixed Models

4.1.1.5 Medical Device Model

4.1.2 Stages of Growing Biomedical Firm

4.2 Agriculture Biotechnology

4.2.1 Production and Economic Impacts

4.2.2 Adoption of Biotechnology Derived Crops

4.2.3 Biotechnology and Biofuels

4.3 Clinical Trials

4.4 Mergers and Acquisitions

4.5 Strategic Alliances

4.6 Biotech Funding (Public, Private & Venture Capital)

4.7 Biotech Research Parks

4.7.1 Cummings Research Park, Huntsville

4.7.2 ASU (Arizona State University) Research Park

4.7.3 Texas Research Park

4.7.4 Delaware Technology Park

4.7.5 Massachusetts Biotechnology Research Park

4.7.6 UK (University of Kentucky) Coldstream Research Campus

4.7.7 InterTech Science Park

4.7.8 Chicago Technology Park

5. US Bio Cluster

5.1 New York

5.2 North-West Pennsylvania

5.3 Massachusetts

5.4 California

5.5 Washington

6. Industry Analysis

6.1 Key Drivers

6.1.1 Increasing Financing Option

6.1.2 Strong and Stable Biotech Sector

6.1.3 Environmental Drivers

6.1.4 Sociological Drivers

6.1.5 Patent System

6.1.6 Federal Funding

6.1.7 FDA Biopharmaceuticals Approvals

6.1.8 Technology

6.2 Opportunities

6.2.1 Opportunity for Developers of Innovative Health Solutions

6.2.2 Biofertilizers/BioPesticides

6.2.3 Agricultural Biotechnology

6.2.4 Biofuel

6.3 Challenges

6.3.1 Consumer Preferences & Market Uncertainty

6.3.2 Cost Pressures

6.3.3 Competition from Developing Countries like India & China

6.3.4 Public Acceptance

6.4 Future Outlook, 2010

7. Key Players and Company Profiles

7.1 Chiron Corporation

7.2 Amgen Inc.

7.3 Biogen Idec, Inc.

7.4 Applied Biosystems

7.5 Genentech

7.6 Baxter International Inc.

8. Annexure I: Government Initiatives and Regulations

8.1 Food and Drug Administration (FDA)

8.1.1 Food

8.1.2 Regulation of Drugs and Biologic Products

8.2 United States Department of Agriculture (USDA)

8.3 United States Environmental Protection Agency (USEPA)

List of Figures:

Figure 3-1: Global - Biotechnology Market (in Billion US$), 2001-2005

Figure 3-2: Global - Biotechnology Market Share by Region (%), 2005

Figure 3-3: Global - Biotechnology Market Share by Segment (%), 2005

Figure 3-4: Global - Forecast for Biotechnology Market (in Billion US$), 2006-2010

Figure 3-5: US - Biotechnology Market (in Billion US$), 2001-2006E

Figure 3-6: US - Biotechnology Market Share by Segment (%), 2005

Figure 3-7: US - Distribution Companies by Segment (%), 2005

Figure 4-1: US - Net Loss Relative to Revenue (%), 1991-2005

Figure 4-2: US - Employment in Biomedical Sector (%), 2005

Figure 4-3: US - Interaction among Players in Biomedical and Healthcare Industries

Figure 4-4: US - Forecast for Clinical Trial Industry (in Billion US$), 2006-2011

Figure 4-5: US - Clinical Trials (in Numbers), 2003-2006E

Figure 4-6: US - Forecast for Clinical Trials (in Number), 2007-2011

Figure 4-7: US - Biotech Financing (in Billion US$), 2004-2006E

Figure 6-1: US - Biotech Financing (in Billion US$), 2004 & 2005

Figure 6-2: US - FDA Approvals (in Numbers), 2000 to Jun’ 2006

Figure 6-3: US - Ethanol Demand (in Billion Gallons), 2006-2008E

Figure 6-4: US - Forecast for Biotech Market (in Billion US$), 2007-2010

List of Tables:

Table 3-1: Biotechnology Industry Segments and Applications

Table 4-1: US - Regulatory History of Biomedical Industry

Table 4-2: US - Stages for Biomedical Companies

Table 4-3: US - Overall Impact of Biotechnology Derived Crops on Agriculture (2001 & 2003 to 2005)

Table 4-4: US - Percentage Adoption of Biotechnology Derived Crops (2003-2005)

Table 4-5: US - Impact of Biotechnology on Crops (Production & Pesticides Reduction), 2005

Table 4-6: US - Impact of Agricultural Biotechnology on Crops, 2005

Table 4-7: US - Impact of Bitechnology Corn on Grain and Ethanol Production (1996-2005)

Table 4-8: US - Selected Biotech M&As (in Million US$), 2005

Table 4-9: US - Biotech Alliances (in Million US$), 2005

Table 4-10: US - Biotech Financing (in Million US$), 2004 & 2005

Table 5-1: Massachusetts - List of FDA Approved Biotechnology Products

Table 6-1: US - FDA Approvals by Drug Name, Company & Type

Table 7-1: Amgen Inc. - Key Financials (in Million US$), 2004 to Sep’ 2006

Table 7-2: Biogen Idec, Inc. - Key Financials (in Million US$), 2004 to Sep’ 2006

Table 7-3: Applied Biosystems - Key Financials (in Billion US$), June’ 2006

Table 7-4: Genentech - Key Financials (in Million US$), 2004 to Sep’ 2006

Table 7-5: Baxter International Inc. - Key Financials (in Million US$), 2005 & Sep’ 2006

Table 8-1: US - Federal Biotechnology Regulatory Framework

Abstract

• Growing at the rate of 13.95% from the year 2005, U.S Biotechnology industry is expected to touch the mark of US$ 131.8 Billion by the end of 2010.
• Biotechnology will play an important role in Agricultural sector by developing large number of genetically modified seeds.
• The biomedical sector accounts for the major share of overall biotech industry in US and will continue to dominate in future as well.
• The clinical trial industry will cross US$ 30 Billion mark by 2011.

• Major market trends in the US Biotechnology industry?
• Where will the market be after 5 years?
• What opportunities exist in US Biotechnology industry?
• What are the driving factors for the US Biotechnology industry?
• Challenges faced by Biotechnology industry?
• Who are the main players in the US Biotechnology industry?

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 160,000 market research reports, company profiles and country profiles from over 600 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.